Drägerwerk AG & Co. KGaA (LON:0MT8)
48.80
-1.60 (-3.17%)
At close: May 14, 2025
Drägerwerk AG & Co. KGaA Revenue
Drägerwerk AG & Co. KGaA had revenue of 730.26M EUR in the quarter ending March 31, 2025, a decrease of -0.76%. This brings the company's revenue in the last twelve months to 3.37B, up 0.51% year-over-year. In the year 2024, Drägerwerk AG & Co. KGaA had annual revenue of 3.37B, down -0.08%.
Revenue (ttm)
3.37B EUR
Revenue Growth
+0.51%
P/S Ratio
0.32
Revenue / Employee
202.91K EUR
Employees
16,585
Market Cap
904.52M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.37B | -2.62M | -0.08% |
Dec 31, 2023 | 3.37B | 328.28M | 10.78% |
Dec 31, 2022 | 3.05B | -283.19M | -8.51% |
Dec 31, 2021 | 3.33B | -77.86M | -2.29% |
Dec 31, 2020 | 3.41B | 625.45M | 22.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Drägerwerk AG & Co. KGaA News
- 14 days ago - Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Drägerwerk AG & Co. KGaA GAAP EPS of €6.61, revenue of €3.37B - Seeking Alpha
- 6 weeks ago - Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Drägerwerk AG & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha